3D model is for representation purpose only.
.
.
GKRKKKGKLGKKRPRSRC | Doxorubicin |
Identification | |
---|---|
ConjuPepDB ID | cpd01249 |
Smiles | |
Molecular weight | 2635.49 |
Molecular formula | C116H198N38O30S |
Chemical name | Peptide information |
Sequence (one letter) | GKRKKKGKLGKKRPRSRC |
Length | 18 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 916443-72-6 |
Other information | |
---|---|
Application | Antitumor therapy, colon and breast tumors |
Additional function | improved efficacy and circumventing resistance |
Pharmacological class | anticancer |
Conjugate type | sulfide |
Linker | no |
Small molecule | Doxorubicin |
Small molecule CAS | 23214-92-8 |
Structure method | 1H NMR, HPLC |
NMR solvent | DMSO-d6 |
Calculated properties | |
---|---|
LogP | -15.61743 |
Rotatable bonds | 89 |
H bond donor | 43 |
H bond acceptor | 51 |
Polar surface area (PSA) | 1185.04000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell) | 2006 | Meyer-Losic, Florence; Quinonero, Jerome; Dubois, Vincent; Alluis, Bertrand; Dechambre, Mireille; Michel, Matthieu; Cailler, Francoise; Fernandez, Anne-Marie; Trouet, Andre; Kearsey, Jonathan | Journal of Medicinal Chemistry |